Phage Based Diagnostics

01359 231856

Twitter Youtube Linkedin Envelope
  • Home
  • About
    • About PBD Biotech
    • Industry Awards
    • Management Team
    • International
  • Actiphage
    • About Actiphage
    • Benefits of Actiphage
    • Rapid detection of mycobacterial disease
  • Bovine
    • Bovine TB
    • Johne’s Disease
    • Dairy Industry
  • Latest
    • Articles
    • Events
  • Case Studies
  • Research
  • Contact
    • Product Order Form
    • Contacting us
Menu
  • Home
  • About
    • About PBD Biotech
    • Industry Awards
    • Management Team
    • International
  • Actiphage
    • About Actiphage
    • Benefits of Actiphage
    • Rapid detection of mycobacterial disease
  • Bovine
    • Bovine TB
    • Johne’s Disease
    • Dairy Industry
  • Latest
    • Articles
    • Events
  • Case Studies
  • Research
  • Contact
    • Product Order Form
    • Contacting us

First Venison talk on new TB test for deer

Date: 18 September 2019

Dr Cath Rees, chief scientific offer at PBD Biotech, has been invited to talk to the First Venison group at their annual AGM.
Deer

Tuberculosis (TB) is a disease that occurs throughout the world and affects many different species. It affects farm livestock, wildlife and also humans.

PBD Biotech has developed Actiphage®, a blood test that provides early detection of TB and accurate identification of the strain of mycobacteria.

Actiphage supports effective disease management and many groups with an interest in responsible animal health and welfare are contacting PBD Biotech to discuss how it can benefit their sector.

One such group is First Venison, a British producer group cooperative supplying quality assured farmed venison produced to the highest standards of husbandry and welfare.

Another benefit of Actiphage is that it requires minimal handling of the deer, unlike the conventional TB skin test which uses an immune reaction to indicate that an animal has been infected and therefore requires a follow-up visit by the vet.

First Venison represents the only dedicated supplier group for prime venison in the UK, with a sole purpose of securing the best routes to market and capturing the maximum and most sustainable market value for its members.

Dr Cath Rees, chief scientific offer at PBD Biotech, has been invited to talk to the First Venison group at their annual AGM, held at the JCB World Headquarters on Wednesday, 18 September 2019.

The title for the presentation will be ‘Actiphage testing for MAP and bovine TB in deer – update on progress and legislative framework’.

Share:
  • Events, Other animals
  • Deer, event

Related posts

Loading...
Arden Farms deer

Arden Farms first to test deer for Johne’s Disease using Actiphage

October 25, 2021
Arden Farms are the first to use the Actiphage® blood test to test their herd of Red Deer for Johne’s Disease. This wasting condition is difficult to detect as it can lay dormant in the animal for many years until...
Arden Farms deer

Arden Farms first to test deer for Johne’s Disease using Actiphage

October 25, 2021
Arden Farms are the first to use the Actiphage® blood test to test their herd of Red Deer for Johne’s...
Dr Cath Rees, PBD Biotech Chief Scientific Officer

18 May 2021

Rebuilding Thriving Local Economies

May 5, 2021
Businesses across the country have seen for themselves the impact of pandemic – but this has been the living nightmare for some dairy farmers for years. Dr Cath Rees, Chief Scientific Officer, PBD Biotech, developers of an accurate blood and...
Dr Cath Rees, PBD Biotech Chief Scientific Officer

18 May 2021

Rebuilding Thriving Local Economies

May 5, 2021
Businesses across the country have seen for themselves the impact of pandemic – but this has been the living nightmare...
Fiji

27-28 November 2019

PBD Biotech invited to speak at Fiji Bovine TB Eradication Forum

November 7, 2019
Dr Ben Swift, co-founder of PBD Biotech, has been invited by Fiji’s Ministry of Agriculture to speak at its 2nd Bovine Brucellosis and Tuberculosis Eradication Campaign (BTEC) Forum on 27 and 28 November 2019.
Fiji

27-28 November 2019

PBD Biotech invited to speak at Fiji Bovine TB Eradication Forum

November 7, 2019
Dr Ben Swift, co-founder of PBD Biotech, has been invited by Fiji’s Ministry of Agriculture to speak at its 2nd...
Red deer

First Venison Group reviews new Actiphage blood test for deer herds

October 28, 2019
To support its members in keeping their deer herds disease free, the First Venison Group invited Dr Cath Rees, co-founder of PBD Biotech, to talk about the new test for MAP and other mycobacteria at its AGM.
Red deer

First Venison Group reviews new Actiphage blood test for deer herds

October 28, 2019
To support its members in keeping their deer herds disease free, the First Venison Group invited Dr Cath Rees, co-founder...
1 2 Next »

developers of phage-based diagnostics

Contact Us

Registered Company Address
Grosvenor St Paul’s
Grosvenor House
11 St Paul’s Square
Birmingham
B3 1RB
United Kingdom

T: 01359 231856
info@pbdbio.com

Privacy and cookies policy

© 2022 PBD Biotech Ltd

design: out of house

  • Follow Us!
PBD Biotech

More reasons to invest in better diagnostics for #tuberculosis 1.6 million preventable deaths and increased pressure on the few treatments available. #EndTB

Read More
PBD Biotech

Delighted Dr Marie Roskrow is the new Chair @PBDBiotech to support development of our rapid TB diagnostic. A physician-scientist she brings expertise from @KinomicaLtd @ImevaX along with Patrys Limited, METALINEAR LIMITED, ArcticZymes Technologies

Read More
PBD Biotech

Testing 4 tuberculosis gained renewed attention in 2022 reports @360DxNews Highlighting $30m funding @UNITAID for @FINDdx also @PBDBiotech gaining $2.9M for its blood-based test to predict which individuals with latent TB will progress to active disease

Read More